Published in CMAJ on November 14, 2016
Chronic obstructive pulmonary disease and Occam's razor. CMAJ (2017) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86
Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med (1998) 32.43
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2003) 10.97
International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet (2007) 10.12
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol (2009) 5.65
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J (2008) 3.67
Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction. Can J Diabetes (2013) 3.46
A quantitative measure of continuity of care. Med Care (1977) 3.34
Spirometry utilization for COPD: how do we measure up? Chest (2007) 2.77
Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet (2011) 2.65
Identifying individuals with physcian diagnosed COPD in health administrative databases. COPD (2009) 2.61
Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J (2006) 2.34
Performance of the ACG case-mix system in two Canadian provinces. Med Care (2001) 2.27
What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J (2003) 2.02
Attitudes of physicians toward objective measures of airway function in asthma. Am J Med (2003) 1.80
Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol (1991) 1.60
Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD. Chest (2007) 1.57
Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study. Ann Intern Med (2011) 1.55
Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD. Chest (2015) 1.49
Spirometry use in clinical practice following diagnosis of COPD. Chest (2006) 1.43
How often is diagnosis of COPD confirmed with spirometry? Respir Med (2010) 1.40
Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trial. Respir Med (2010) 1.11
Do spirometry and regular follow-up improve health outcomes in general practice patients with asthma or COPD? A cluster randomised controlled trial. Med J Aust (2010) 0.98
Use of spirometry in the diagnosis of chronic obstructive pulmonary disease and efforts to improve quality of care. Transl Res (2009) 0.90
Patient and physician factors associated with pulmonary function testing for COPD: a population study. Chest (2014) 0.87
Medication use patterns associated with spirometry in diagnosing COPD. COPD (2008) 0.84
Pulmonary Gas Exchange Abnormalities in Mild Chronic Obstructive Pulmonary Disease. Implications for Dyspnea and Exercise Intolerance. Am J Respir Crit Care Med (2015) 2.78
Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma. JAMA (2017) 1.47
History of Asthma in Patients with Chronic Obstructive Pulmonary Disease. A Comparative Study of Economic Burden. Ann Am Thorac Soc (2016) 1.39
Ventilation Heterogeneity in Never-smokers and COPD:: Comparison of Pulmonary Functional Magnetic Resonance Imaging with the Poorly Communicating Fraction Derived From Plethysmography. Acad Radiol (2016) 1.39
Undiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD Study. Am J Respir Crit Care Med (2016) 0.84
Diagnostic Instability and Reversals of COPD Diagnosis in Subjects with Mild to Moderate Airflow Obstruction. Am J Respir Crit Care Med (2017) 0.83
Excess medical costs in patients with asthma and the role of comorbidity. Eur Respir J (2016) 0.83
Progression from Asthma to Chronic Obstructive Pulmonary Disease. Is Air Pollution a Risk Factor? Am J Respir Crit Care Med (2016) 0.81
Ultrashort echo time MRI biomarkers of asthma. J Magn Reson Imaging (2016) 0.77
Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: A population study of prevalence, incidence and mortality. PLoS One (2017) 0.75
Mechanisms of exertional dyspnoea in symptomatic smokers without COPD. Eur Respir J (2016) 0.75
Effect of age-related ventilatory inefficiency on respiratory sensation during exercise. Respir Physiol Neurobiol (2014) 0.75
Ten-year trends in direct costs of asthma: a population-based study. Allergy (2016) 0.75
On the Potential Role of MRI Biomarkers of COPD to Guide Bronchoscopic Lung Volume Reduction. Acad Radiol (2017) 0.75
Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori. Respir Res (2017) 0.75
Free-breathing Functional Pulmonary MRI: Response to Bronchodilator and Bronchoprovocation in Severe Asthma. Acad Radiol (2017) 0.75
Looking beyond cigarettes: Are Ontario adolescents with asthma less likely to smoke e-cigarettes, marijuana, waterpipes or tobacco cigarettes? Respir Med (2016) 0.75
Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma? Eur Respir J (2017) 0.75
Excess economic burden of comorbidities in COPD: a 15-year population-based study. Eur Respir J (2017) 0.75
The impact of a history of asthma on long-term outcomes of people with newly diagnosed chronic obstructive pulmonary disease: A population study. J Allergy Clin Immunol (2016) 0.75
MRI ventilation abnormalities predict quality-of-life and lung function changes in mild-to-moderate COPD: longitudinal TINCan study. Thorax (2017) 0.75
Pulmonary MRI morphometry modeling of airspace enlargement in chronic obstructive pulmonary disease and alpha-1 antitrypsin deficiency. Magn Reson Med (2017) 0.75
Understanding resource utilization and mortality in COPD to support policy making: A microsimulation study. PLoS One (2020) 0.75